These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33276347)

  • 1. Novel rivaroxaban-loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile.
    Machado ME; de Souza Furtado P; da Costa Bernardes Araújo C; Simon A; de Moraes MC; Rodrigues Pereira da Silva LC; do Carmo FA; Cabral LM; Sathler PC
    Nanotechnology; 2021 Mar; 32(13):135101. PubMed ID: 33276347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arg-Specific serine Protease-Targeted edoxaban tosylate monohydrate-Poly (lactic-co-glycolic acid) Nanoparticles: Investigating Stuart-Prower factor targeting and intestinal distribution through Ex-Vivo fluorescent visualization.
    Pazhani P; Prakash Dharmian J; Arumugam S; Pazhani P; Vara Prasad Medapati V
    Eur J Pharm Biopharm; 2024 Oct; 203():114459. PubMed ID: 39168255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect.
    Anwer MK; Mohammad M; Iqbal M; Ansari MN; Ezzeldin E; Fatima F; Alshahrani SM; Aldawsari MF; Alalaiwe A; Alzahrani AA; Aldayel AM
    J Thromb Thrombolysis; 2020 Apr; 49(3):404-412. PubMed ID: 31898270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats.
    de Souza Furtado P; Agnes Silva Camargo de Oliveira A; Santiago Rodrigues P; Rita Santiago de Paula Gonçalves A; Raphaella Autran Colaço A; Pinheiro da Costa S; Muniz da Paz M; Wetler Meireles Carreiros Assumpção P; Pereira Rangel L; Simon A; Almada do Carmo F; Mendes Cabral L; Cunha Sathler P
    Eur J Pharm Biopharm; 2023 Sep; 190():184-196. PubMed ID: 37517449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Dose Proportionality of Rivaroxaban Nanocrystals.
    Demir H; Gulsun T; Ozkan MH; Nemutlu E; Sahin S; Öner L
    AAPS PharmSciTech; 2020 Aug; 21(6):228. PubMed ID: 32767034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban-loaded SLNs with treatment potential of deep vein thrombosis: in-vitro, in-vivo, and toxicity evaluation.
    Luo X; Saleem A; Shafique U; Sarwar S; Ullah K; Imran M; Zeb A; Din FU
    Pharm Dev Technol; 2023 Sep; 28(7):625-637. PubMed ID: 37366661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate.
    Tanna V; Vora A; Shah P; Nair AB; Shah J; Sawarkar SP
    AAPS PharmSciTech; 2024 Sep; 25(7):205. PubMed ID: 39237656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and bioactivity evaluation of hepatocyte growth factor-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Xian WJ; Wang XE; Zhang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):217-223. PubMed ID: 29502063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and effect of storage on the stability of enriched flavonoid fraction of
    Santos TCD; Battisti MA; Ortmann CF; Reginatto FH; Simões CMO; de Campos AM
    Pharm Dev Technol; 2018 Dec; 23(10):998-1006. PubMed ID: 27707078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles.
    Nozal V; Rojas-Prats E; Maestro I; Gil C; Perez DI; Martinez A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats.
    Anwer MK; Mohammad M; Ezzeldin E; Fatima F; Alalaiwe A; Iqbal M
    Int J Nanomedicine; 2019; 14():1587-1595. PubMed ID: 30880967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.
    Kim DH; Nguyen TN; Han YM; Tran P; Rho J; Lee JY; Son HY; Park JS
    Drug Deliv; 2021 Dec; 28(1):2268-2277. PubMed ID: 34668836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment.
    Valle IV; Machado ME; Araújo CDCB; da Cunha-Junior EF; da Silva Pacheco J; Torres-Santos EC; da Silva LCRP; Cabral LM; do Carmo FA; Sathler PC
    Nanotechnology; 2019 Nov; 30(45):455102. PubMed ID: 31365912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and
    Narvekar P; Bhatt P; Fnu G; Sutariya V
    Assay Drug Dev Technol; 2019; 17(4):167-177. PubMed ID: 31184962
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment.
    Chevalier MT; Garona J; Sobol NT; Farina HG; Alonso DF; Álvarez VA
    Nanomedicine (Lond); 2018 Nov; 13(22):2835-2849. PubMed ID: 30430901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity against Zika virus of a new formulation of curcumin in poly lactic-co-glycolic acid nanoparticles.
    Pacho MN; Pugni EN; Díaz Sierra JB; Morell ML; Sepúlveda CS; Damonte EB; García CC; D'Accorso NB
    J Pharm Pharmacol; 2021 Mar; 73(3):357-365. PubMed ID: 33793877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.